Sec. 14. Arbitration
69 words·~1 min read·
/bill/113/s/627/is/section-14A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
In the case of a drug that is on the market on October 1, 2014, and subject to patents owned by a party other than the person who first received market clearance for the drug, the Board shall establish an arbitration procedure to determine an equitable division of any prize payments under this Act among the patent owners and the person who first received market clearance for the drug.